KORU Medical Systems, Inc.

NasdaqCM:KRMD Stock Report

Market Cap: US$99.2m

KORU Medical Systems Past Earnings Performance

Past criteria checks 0/6

KORU Medical Systems's earnings have been declining at an average annual rate of -62.4%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 7.9% per year.

Key information

-62.4%

Earnings growth rate

-62.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate7.9%
Return on equity-67.5%
Net Margin-48.2%
Next Earnings Update01 May 2024

Recent past performance updates

Recent updates

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

Feb 15
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Sep 21
We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

Jul 14
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Sep 27
We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Oct 27
Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Aug 14
Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Feb 22
Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

Jan 27
Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

KORU Medical Systems: A Razor & Razor Blade Story

Jan 11

Is Repro Med Systems, Inc. (NASDAQ:KRMD) Trading At A 50% Discount?

Dec 29
Is Repro Med Systems, Inc. (NASDAQ:KRMD) Trading At A 50% Discount?

Have Insiders Been Buying Repro Med Systems, Inc. (NASDAQ:KRMD) Shares This Year?

Dec 03
Have Insiders Been Buying Repro Med Systems, Inc. (NASDAQ:KRMD) Shares This Year?

The Independent Chairman of the Board of Repro Med Systems, Inc. (NASDAQ:KRMD), R. Fletcher, Just Bought 77% More Shares

Dec 03
The Independent Chairman of the Board of Repro Med Systems, Inc. (NASDAQ:KRMD), R. Fletcher, Just Bought 77% More Shares

Repro Med Systems: Fair View Of The Fundamentals

Nov 18

Repro Med Systems, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 05

Repro Med Systems EPS misses by $0.01, misses on revenue

Nov 03

Revenue & Expenses Breakdown
Beta

How KORU Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:KRMD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2329-14206
30 Sep 2329-8196
30 Jun 2329-8206
31 Mar 2329-9205
31 Dec 2228-9215
30 Sep 2227-8214
30 Jun 2225-8204
31 Mar 2224-6183
31 Dec 2123-5182
30 Sep 2121-4162
30 Jun 2121-3151
31 Mar 2123-3141
31 Dec 2024-1121
30 Sep 20260121
30 Jun 20270111
31 Mar 20251101
31 Dec 19231101
30 Sep 19210101
30 Jun 1919090
31 Mar 1918090
31 Dec 1817180
30 Sep 1818280
30 Jun 1817280
31 Mar 1816180
31 Dec 1716180
28 Feb 1712-180
30 Nov 1613070
31 Aug 1613070
31 May 1613160
29 Feb 1612160
30 Nov 1512160
31 Aug 1512150
31 May 1511150
28 Feb 1511150
30 Nov 1410140
31 Aug 1410140
31 May 149140
28 Feb 149140
30 Nov 138140
31 Aug 138040
31 May 138140

Quality Earnings: KRMD is currently unprofitable.

Growing Profit Margin: KRMD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KRMD is unprofitable, and losses have increased over the past 5 years at a rate of 62.4% per year.

Accelerating Growth: Unable to compare KRMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: KRMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: KRMD has a negative Return on Equity (-67.51%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.